Literature DB >> 14574241

Clinical and methodological utility of a composite outcome measure for alcohol treatment research.

Allen Zweben1, Ron A Cisler.   

Abstract

BACKGROUND: How to capture different response patterns resulting from alcohol treatment has been a troublesome issue for alcohol researchers. A composite measure is one approach to capturing multiple treatment outcomes among diverse client populations. This article provides the rationale, development, and work conducted thus far on the composite outcome index and discusses the clinical utility of the measure.
METHODS: With the use of Project MATCH data, the composite outcome measure was examined in relation to self-reported alcohol consumption and alcohol problems and biological markers as well as in relation to other areas of functioning, such as psychiatric dysfunction and quality of life. Also, for assessing the stability of the measure, different composite outcomes statuses were assessed over time.
RESULTS: Individuals with better scores on composite outcome index had fewer percent days abstinent, consumed more alcohol when they drank, had a greater number of alcohol problems, and evidenced higher blood levels as measured by gamma-glutamyltranspeptidase and carbohydrate-deficient transferrin. Individuals with poorer composite outcome statuses had poorer social and behavioral role functioning and mental and physical health-related quality of life. Findings on short- and long-term composite outcome statuses revealed that only a minority of clients (30%) sustained a remitted status (i.e., abstinent or moderate drinking without problems) over the 1-year follow-up, and fully 70% of the clients had reached a nonremitted status (i.e., heavy drinking and/or problems) on the composite measure at one or more time points during the 12-month follow-up.
CONCLUSIONS: The composite outcome index could be used usefully along with singular measures of consumption to obtain a more complete picture of what has occurred among clients posttreatment. Future work will involve the testing of the composite outcome index with other client populations and/or different treatments to further our understanding of the varying response patterns found among alcohol-dependent clients.

Entities:  

Mesh:

Year:  2003        PMID: 14574241     DOI: 10.1097/01.ALC.0000091237.34225.D7

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  16 in total

1.  Evaluating Alcoholics Anonymous's effect on drinking in Project MATCH using cross-lagged regression panel analysis.

Authors:  Stephen Magura; Charles M Cleland; J Scott Tonigan
Journal:  J Stud Alcohol Drugs       Date:  2013-05       Impact factor: 2.582

2.  Factors associated with favorable drinking outcome 12 months after hospitalization in a prospective cohort study of inpatients with unhealthy alcohol use.

Authors:  Nicolas Bertholet; Debbie M Cheng; Tibor P Palfai; Richard Saitz
Journal:  J Gen Intern Med       Date:  2010-05-18       Impact factor: 5.128

3.  The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders.

Authors:  Raymond F Anton; Raye Z Litten; Daniel E Falk; Joseph M Palumbo; Raymond T Bartus; Rebecca L Robinson; Henry R Kranzler; Thomas R Kosten; Roger E Meyer; Charles P O'Brien; Karl Mann; Didier Meulien
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

4.  What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?

Authors:  Brian D Kiluk; Garrett M Fitzmaurice; Eric C Strain; Roger D Weiss
Journal:  Addiction       Date:  2018-06-27       Impact factor: 6.526

5.  Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders.

Authors:  Clara M Bradizza; Stephen A Maisto; Paula C Vincent; Paul R Stasiewicz; Gerard J Connors; Nicole D Mercer
Journal:  J Consult Clin Psychol       Date:  2009-12

6.  OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.

Authors:  Gabor Oroszi; Raymond F Anton; Stephanie O'Malley; Robert Swift; Helen Pettinati; David Couper; Qiaoping Yuan; David Goldman
Journal:  Alcohol Clin Exp Res       Date:  2008-11-25       Impact factor: 3.455

7.  A novel application of propensity score matching to estimate Alcoholics Anonymous' effect on drinking outcomes.

Authors:  Stephen Magura; Joseph McKean; Scott Kosten; J Scott Tonigan
Journal:  Drug Alcohol Depend       Date:  2012-10-03       Impact factor: 4.492

Review 8.  Alcohol use disorder clinical course research: informing clinicians' treatment planning now and in the future.

Authors:  Stephen A Maisto; Megan Kirouac; Katie Witkiewitz
Journal:  J Stud Alcohol Drugs       Date:  2014-09       Impact factor: 2.582

9.  Social networks and their influence on drinking behaviors: differences related to cognitive impairment in clients receiving alcoholism treatment.

Authors:  Jennifer F Buckman; Marsha E Bates; Ron A Cisler
Journal:  J Stud Alcohol Drugs       Date:  2007-09       Impact factor: 2.582

10.  Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme.

Authors:  Pierre Lahmek; Ivan Berlin; Laurent Michel; Chafia Berghout; Nadine Meunier; Henri-Jean Aubin
Journal:  Int J Med Sci       Date:  2009-05-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.